Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | CTSS | P25774 | 1/20 | 0.53 |
| ▸ | CTSK | P43235 | 1/20 | 0.53 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.47 |
| ▸ | BIRC2 | Q13490 | 3/20 | 0.47 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.45 |
| ▸ | PSEN2 | P49810 | 4/20 | 0.45 |
| ▸ | APH1B | Q8WW43 | 4/20 | 0.45 |
| ▸ | NCSTN | Q92542 | 4/20 | 0.45 |
| ▸ | APH1A | Q96BI3 | 4/20 | 0.45 |
| ▸ | PSENEN | Q9NZ42 | 4/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | REN | P00797 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12555973 | 1.00 | CTSL (0.53) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL12588811 | 1.00 | CTSL (0.53) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL28061324 | 1.00 | CTSL (0.53) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL30064542 | 0.93 | CTSL (0.55) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL24130734 | 0.91 | CTSL (0.52) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL1176795 | 0.90 | CTSL (0.62) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL1026997 | 0.90 | CTSL (0.62) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL1026994 | 0.90 | CTSL (0.62) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL56907 | 0.89 | CTSL (0.60) | CTSLCTSBCTSSCTSKCAPN1 | |
| SCHEMBL55832 | 0.89 | CTSL (0.60) | CTSLCTSBCTSSCTSKCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-3786151-B1 | METHOD FOR PRODUCING AMIDE COMPOUND | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2023-06-07 | — | — | EP | disclosed |
| CN-112020492-B | Method for producing amide compound | 学校法人中部大学 | 2023-05-05 | — | — | CN | disclosed |
| US-11512108-B2 | Method for producing amide compound | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2022-11-29 | — | — | US | disclosed |
| EP-4053101-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | Chubu University Educational Foundation (JP) | 2022-09-07 | — | — | EP | disclosed |
| CN-105622716-A | Cyclic dipeptide used for wound healing | GOOD DOCTOR PHARMACEUTICAL GROUP CO LTD | 2016-06-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | NAAA, FAAH, FAAH2 | CTSL 1244/4885CTSB 577/4885CTSS 392/4885 |
| US-11512108-B2 | Method for producing amide compound | BCAT2, ASNS, VIP | CTSL 630/4885CTSB 759/4885CTSS 873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.